Xeltis
Manufacturing · Netherlands · 11-50 Employees
View Company Info for Free
Overview
Headquarters
31 De Lismortel, Eindhoven, North Braban...Phone Number
+31 407517614Website
www.xeltis.comRevenue
$10 MillionIndustry
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
1
1
1
1
1
About Xeltis
A clinical-stage medical device company, Xeltis has developed the most advanced polymer-based restorative devices for cardiovascular treatment. Xeltis' restorative devices comprise heart valves and small diameter blood vessels for coronary artery bypass graft (CABG) surgery and for hemodialysis vascular access. Xeltis was formed through the merger of two Dutch/Swiss university spin-offs and it currently has operations in The Netherlands and in the USA. Xeltis' investors include venture capital funds Kurma Partners, LSP, VI Partners and Ysios Capital as well as a number of private investors. CAUTION: The Xeltis technology is an investigational device and NOT approved for sale. 1Morales DL, Herrington C, Bacha EA, Morell VO, Prodán Z, Mroczek T, Sivalingam S, Cox M, Bennink G and Asch FM (2021) A Novel Restorative Pulmonary Valve Conduit: Early Outcomes of Two Clinical Trials.Explore more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Xeltis your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Funding: Get notified immidiatlly once Xeltis has new funding data
Product Launch: Get notified when Xeltis launches new products
Click to see if Xeltis had a recent Job posting/layoffs
Earning: See what the market has to say on Xeltis recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at Xeltis
Check out if Xeltis is spiking on competitors!
Xeltis, which may be a good buyer, showed buying intent in Masked Content Topic
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check if Xeltis has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
Recommended Actions
Reach out to Masked Content who joined Xeltis as Masked Content
Find 3 more new buyers
Company Profile Activity
Activity Insights
Xeltis is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Xeltis is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Xeltis.
Xeltis financials insights
Gather financial insights about Xeltis, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2015
Series B
$3.3M
2017
Series C
$52.8M
2023
Series D
$34M
2026
Other Financing Round
$23.3M
Xeltis Tech Stack
A closer look at the technologies used by Xeltis
Most Recent Scoops
Funding
Funding
Project
Laboratory Operations, Medical Research, Clinical Operations
Open Position
Funding
Funding
Xeltis News & Media
Xeltis raises an additional €20.5m of funding to advance aXess™ toward FDA approval and US commercial launch
Xeltis has raised €20.5m of funding from new and excisting shareholders to advance aXess™ toward FDA approval and US commercial launchXeltis makes first commercial implant of aXess™, its vascular access device for hemodialysis
Xeltis announces the official start of the European commercialization of aXess™, marked by the successful treatment of the first commercial patientOver half of target patients enrolled in Xeltis’ aXess US pivotal trial
The company plans to enrol a total of 140 patients in the trial of the aXess device.Xeltis exceeds 50% enrollment in US Pivotal trial for aXess™, its vascular access device for hemodialysis
Xeltis announces that it has exceeded 50% enrollment in its US pivotal trial for aXess™
Read more news
Top Manufacturing Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Xeltis
Sign Up For FreeTo access detailed company insights
A clinical-stage medical device company, Xeltis has developed the most advanced polymer-based restorative devices for cardiovascular treatment. Xeltis' restorative devices comprise heart valves and small diameter blood vessels for coronary artery bypass graft (CABG) surgery and for hemodialysis vascular access. Xeltis was formed through the merger... Read More
